We are live on
!
Find out more
NLGIA
Nippon Life Global Investors Americas Portfolio holdings
AUM
$2.51B
1-Year Est. Return
41.64%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+41.64%
3 Year Est. Return
+173.3%
5 Year Est. Return
+246.87%
10 Year Est. Return
+972.43%
AUM
$1.52B
AUM Growth
+$117M
(+8.4%)
Cap. Flow
-$3.56M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
37.3%
Holding
155
New
11
Increased
33
Reduced
40
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$13.1M |
| 2 |
Mastercard
MA
|
+$12.8M |
| 3 |
General Motors
GM
|
+$4.62M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$4.07M |
| 5 |
Goldman Sachs
GS
|
+$4.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$9.12M |
| 2 |
Analog Devices
ADI
|
+$5.66M |
| 3 |
Intuit
INTU
|
+$5.53M |
| 4 |
Illinois Tool Works
ITW
|
+$5.05M |
| 5 |
Pfizer
PFE
|
+$4.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.16% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 12.91% |
| 4 | Communication Services | 12.05% |
| 5 | Consumer Discretionary | 11.58% |
Similar funds
CM
Q
OBAM
FFA
LC
SG
TW
ECP
Nippon Life Global Investors Americas's Q3 2020 Portfolio in Review
As of Q3 2020, Nippon Life Global Investors Americas held 155 positions worth $1.52B, up 8.4% from $1.4B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Nippon Life Global Investors Americas's Q3 2020 filing shows 11 new, 33 increased, 40 reduced and 12 closed positions. Its largest new stake was Merck: 167,146 shares worth $13.2M. The largest sale was Medtronic, an estimated $9.12M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Nippon Life Global Investors Americas's largest Q3 2020 buy was Merck: 167,146 shares worth $13.2M.
- Nippon Life Global Investors Americas added most to IHS Markit Ltd. Common Shares in Q3 2020, an estimated $4.07M increase.
- Nippon Life Global Investors Americas's biggest Q3 2020 reduction was Pfizer, cutting an estimated $4.49M.
- Nippon Life Global Investors Americas fully exited Medtronic in Q3 2020, selling an estimated $9.12M.
- Nippon Life Global Investors Americas's ten largest holdings make up 37% of its $1.52B portfolio in Q3 2020.
- Nippon Life Global Investors Americas opened 11 new positions and closed 12 in Q3 2020.
- Nippon Life Global Investors Americas's portfolio value rose 8.4% quarter-over-quarter to $1.52B.
Based on Nippon Life Global Investors Americas's 13F filing for Q3 2020, filed 16 Nov 2020.